Anti-tumor therapeutic effects in mice treated with Listeria monocytogenes (Lm)-LLO immunotherapy in combination with PD-L1

被引：0
|
作者：
Molli, Poonam [1 ]
Wallecha, Anu [1 ]
机构：
[1] Advaxis Inc, Princeton, NJ USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2513
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
    Bevins, Nicholas J.
    Okamura, Ryosuke
    Montesion, Meagan
    Adashek, Jacob J.
    Goodman, Aaron M.
    Kurzrock, Razelle
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (04) : 90 - 97
  • [42] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Hao Zhang
    Lin Liu
    Jinbo Liu
    Pengyuan Dang
    Shengyun Hu
    Weitang Yuan
    Zhenqiang Sun
    Yang Liu
    Chengzeng Wang
    Molecular Cancer, 22
  • [43] Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity
    Sam, Johannes
    Colombetti, Sara
    Fauti, Tanja
    Roller, Andreas
    Biehl, Marlene
    Fahrni, Linda
    Nicolini, Valeria
    Perro, Mario
    Nayak, Tapan
    Bommer, Esther
    Schoenle, Anne
    Karagianni, Maria
    Le Clech, Marine
    Steinhoff, Nathalie
    Klein, Christian
    Umana, Pablo
    Bacac, Marina
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Triggering anti-tumor immunity by overexpressing of MAVS in combination with PD-L1 ICB in immune insensitive colorectal cancers.
    Hwang, Bin-Jin
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Zhang, Hao
    Liu, Lin
    Liu, Jinbo
    Dang, Pengyuan
    Hu, Shengyun
    Yuan, Weitang
    Sun, Zhenqiang
    Liu, Yang
    Wang, Chengzeng
    MOLECULAR CANCER, 2023, 22 (01)
  • [46] Anti-tumor effects of genetic deletion of PD-1 in adult mice
    Raghavan, Sukaya
    Tovbis, Nataliya Shifrin
    Kochel, Christina
    Malefyt, Rene deWaal
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 339 - 340
  • [47] FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
    Dahan, Rony
    Sega, Emanuela
    Engelhardt, John
    Selby, Mark
    Korman, Alan J.
    Ravetch, Jeffrey V.
    CANCER CELL, 2015, 28 (03) : 285 - 295
  • [48] Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapy
    Qin, Bao-Dong
    Jiao, Xiao-Dong
    Zang, Yuan-Sheng
    MEDICAL HYPOTHESES, 2018, 116 : 111 - 113
  • [49] Small peptides elicit anti-tumor effects in CT26 model through blocking PD-L1/PD-1
    Gao, Yanfeng
    Liu, Beiyuan
    Chang, Haonan
    Li, Wenwen
    Zhou, Yang
    Li, Guodong
    Qi, Yuanming
    Liu, Lei
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [50] Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin
    Chen, Shaomeng
    Zhou, Xiuman
    Yang, Xin
    Li, Wanqiong
    Li, Shuzhen
    Hu, Zheng
    Ling, Chen
    Shi, Ranran
    Liu, Juan
    Chen, Guanyu
    Song, Nazi
    Jiang, Xianxing
    Sui, Xinghua
    Gao, Yanfeng
    BIOMOLECULES, 2021, 11 (09)
12345